Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma
Assistance Publique Hopitaux De Marseille
Quelling of Excitotoxicity in Acute Stroke With Ketamine
Lower Merion Neurology Research Foundation
Ketamine Treatment for PTSD and MDD in TBI
Minneapolis Veterans Affairs Medical Center
Psilocybin Administration With 5-HT1a Blockade
Johns Hopkins University
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
Janssen Research & Development, LLC
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Joshua Rosenblat
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Neutrolis
Psilocybin as a Treatment for Chronic Pain in Smokers
Yale University
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Centre for Addiction and Mental Health
MDMA-assisted Therapy for Fibromyalgia
Spaulding Rehabilitation Hospital
Mindfulness-based Psilocybin Therapy for PTSD
Anthony P King
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Yale University
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Johns Hopkins University
MDMA-Assisted Massed Exposure Therapy for PTSD
Emory University
MDMA Therapy in Veterans With PTSD
Sunstone Medical
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Centre Hospitalier Universitaire de Nīmes
Comparison of Two General Anesthesia Maintenance Strategies on Intraoperative Visibility During Arthroscopic Rotator Cuff Surgery: A Randomized Trial
Centre Hospitalier Universitaire de Nice
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
University Hospital, Montpellier
A Study of Psychedelics in Healthy Older Adults With Low Well-being
Jennifer Mitchell
Ketamine in Severe Traumatic Brain Injury
University of Texas Southwestern Medical Center
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Unity Health Toronto
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Sunstone Medical
MDMA Assisted Therapy for BN
Icahn School of Medicine at Mount Sinai
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
VA Office of Research and Development
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Francisco A Moreno
Subjective Experience Following Psilocybin
University of Calgary
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
Hospital Italiano de Buenos Aires
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Definium Therapeutics US, Inc.
Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy
Fundacio Puigvert
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
University of New Mexico
An International Federated Model for Wearable-derived Remote Longitudinal Motor Monitoring in Young Children With Spinal Muscular Atrophy Compared With Healthy Controls: Active-NBS Study (UK)
University of Oxford
Psilocybin to Treat Depression in Spinal Cord Injury
James J. Peters Veterans Affairs Medical Center
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa
Region Skane
Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
Zeliha Alicikus
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Massachusetts General Hospital
Ketamine and Propofol NeuroImaging
Keith M Vogt
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
University of Colorado, Denver
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
University of Pennsylvania
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Gustavo Vazquez
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Mohsen Saidinejad
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
University Hospital, Basel, Switzerland
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Salma Health, Inc.
Psilocybin for Prolonged Grief Disorder
University of Virginia
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
University Hospital, Basel, Switzerland
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
University of Virginia
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Prospective IR-led Sedation Feasibility
CAMC Health System
The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
National and Kapodistrian University of Athens
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.